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Ana Maria Carvalho,b Celestino Santos-Buelga,c Isabel C. F. R. Ferreira*b and
P. F. Santos*d
After a period of indiﬀerence, in which synthetic compounds were favored, there is an increasing interest
in the study of the biological properties of plants and the active principles responsible for their therapeutic
properties. Geranium molle L. has been used in the Portuguese folk medicine for the treatment of various
ailments including cancer but, unlike many of the species from the Geranium genus, its phytochemical
characterization and biological activity are virtually unexplored. In this study a G. molle sample from Trás-
os-Montes, north-eastern Portugal, was chemically characterized regarding nutritional value, free sugars,
organic acids, fatty acids and tocopherols, and several aqueous (decoction, infusion) and organic
(n-hexane, dichloromethane, ethyl acetate, acetone, methanol) extracts of the plant were assessed for
their bioactive properties. The antioxidant activity was evaluated by means of the free radicals scavenging
activity, reducing power and inhibition of lipid peroxidation. The cytotoxicity of the diﬀerent extracts was
assessed in vitro against several human cancer cell lines (breast, lung, cervical and hepatocellular carci-
nomas) and, additionally, their hepatotoxicity was evaluated using a porcine liver primary cell culture.
G. molle was shown to be rich in carbohydrates and proteins, providing tocopherols and essential fatty
acids. Amongst the various extracts, the acetone extract was found to have the highest content of pheno-
lic compounds (mainly ellagitannins, but also some ﬂavone and ﬂavonol glycosides) as well as the highest
antioxidant and cytotoxic activities. To the best of our knowledge, this is the ﬁrst report on the chemical
composition and bioactive properties of G. molle.
1. Introduction
The use of medicinal plants to improve health was highly
valued in ancient civilizations. Until the mid-nineteenth
century, plants were the main therapeutic agents used by
humans.1,2 After a period of indiﬀerence, in which synthetic
compounds were favored, in recent years increasing interest of
researchers has been observed in the study of the biological
activity of plants and the active principles responsible for their
therapeutic properties.3,4
Geranium molle L., commonly known as Dove’s-foot
Crane’s-bill or Dovesfoot Geranium, is an annual or biennial
herb that belongs to the Geraniaceae family. This plant is
native of Europe, northern Africa, and western Asia. It was
introduced in southern Africa, the Americas, eastern Asia,
Australia, and New Zealand.5,6 Geranium molle L. grows spon-
taneously in cultivated and waste places, open habitats, dunes,
and dry grassland or roadsides, between 0 and 1500 m in
altitude.7,8
Unlike other species of the Geranium genus, namely the
closely related Geranium robertianum L., there seems to be an
almost complete absence of references to the use of Geranium
molle in folk medicine. Exception is made to an ethnopharmaco-
logical study carried out by Neves et al.9 in some regions of
Trás-os-Montes (north east Portugal), where the flowering
aerial parts and roots of the wild plant are traditionally used
to prepare decoctions and infusions for stomach acidity and
stomach ache, gingivitis, eye inflammation and cuts, uterus
inflammation and cancer treatment.
The phytochemistry of the Geranium genus is reasonably
well-known and clearly dominated by phenolic constituents,10
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the most studied classes of compounds being tannins, flavo-
noids and phenolic acids. The phenolic compounds, especially
the flavonoids, have been cited as the main biologically active
components among those found in Geranium species.11 This
class of compounds from Geranium spp. were reported to
exhibit antiviral, antitumor, antithrombotic, hepatoprotective,
anti-inflammatory, antiallergic, antiproliferative, anticancer
and immune stimulant eﬀects.11–13
Although the Geranium genus phytochemistry is relatively
well-known, reports on the chemical composition and biologi-
cal properties of Geranium molle L. cannot be found in the
literature. Therefore, in the present study, a wild sample of
Geranium molle L. was analysed for its nutritional composition
(proteins, fat, carbohydrates and ash) and chemically charac-
terized regarding hydrophilic (sugars, organic acids) and lipo-
philic (fatty acids and tocopherols) molecules. An infusion and
a decoction (common forms of consumption) and diﬀerent
organic extracts were evaluated for their bioactive properties,
namely the antioxidant and antitumor properties, being the
most active extract characterized in terms of phenolic
compounds.
2. Materials and methods
2.1. Standards and reagents
Acetonitrile (99.9%), n-hexane (97%) and ethyl acetate (99.8%)
were of HPLC grade from Fisher Scientific (Lisbon, Portugal).
The fatty acid methyl ester (FAME) reference standard mixture
37 (standard 47885-U) was purchased from Sigma (St Louis,
MO, USA), as also, L-ascorbic acid, Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), organic acids, sugar
standards, acetic acid, formic acid, ellipticine, sulphorhod-
amine B (SRB), trypan blue, trichloroacetic acid (TCA) and Tris.
Phenolic compound standards were purchased from Extra-
synthèse (Genay, France). Tocol (50 mg mL−1) and individual
tocopherols were purchased from Matreya (Pleasant Gap, PA,
USA). 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from
Alfa Aesar (Ward Hill, MA, USA). Foetal bovine serum (FBS),
L-glutamine, Hank’s balanced salt solution (HBSS), trypsin-
EDTA (ethylenediaminetetraacetic acid), penicillin/strepto-
mycin solution (100 U mL−1 and 100 mg mL−1, respectively),
RPMI-1640 and DMEM media were from Hyclone
(Logan, Utah, USA). Water was treated in a Milli-Q water
purification system (TGI Pure Water Systems, Greenville, SC,
USA).
2.2. Plant material
Geranium molle L. specimens in blossom (including thin roots,
basal leaves, ascending stems, upper hairy leaves and flowers)
were collected in Serra da Nogueira, Bragança, north-eastern
Portugal, in March 2015, and subsequently, all dirt and dried
parts were cleaned out. The amount of plant material collected
was around 780 g. Voucher specimens are deposited at the
herbarium of the Escola Superior Agrária de Bragança
(BRESA). The botanical identification was confirmed by the
agronomist Dra. Ana Maria Carvalho of the School of Agricul-
ture, Polytechnic Institute of Bragança (Trás-os-Montes,
Portugal). The sample was lyophilized, reduced to a fine
dried powder (∼20 mesh), mixed to obtain a homogeneous
sample and stored in a refrigerator at −20 °C, protected
from light.
2.3. Chemical characterization
2.3.1. Macronutrient composition of the crude plant
material. The sample was analysed for its nutritional chemical
composition (proteins, fat, carbohydrates and ash) through
standard procedures.14 The crude protein content (N × 6.25) of
the sample was estimated by the macro-Kjeldahl method.
The crude fat was determined by extracting a known weight of
powdered sample with petroleum ether, using a Soxhlet appar-
atus. The ash content was determined by incineration at 600 ±
15 °C. Total carbohydrates were calculated by diﬀerence.
Energy was calculated according to the following equation:
energy (kcal) = 4 × (g protein + g carbohydrate) + 9 × (g fat).
2.3.2. Hydrophilic compounds
Free sugars. Free sugars were determined via high perform-
ance liquid chromatography coupled to a refraction index
detector (HPLC-RI), after an extraction procedure previously
described by the authors15 using melezitose as internal stan-
dard (IS). The equipment consisted of an integrated system
with a pump (Knauer, Smartline system 1000, Berlin,
Germany), a degasser system (Smart line manager 5000) and
an auto-sampler (AS-2057 Jasco, Easton, MD, USA) coupled to
a refraction index (RI) detector (Knauer Smartline 2300). The
chromatographic separation was achieved with a Eurospher
100-5 NH2 column (5 µm, 4.6 × 250 mm, Knauer) operating at
30 °C (7971 R Grace oven). The mobile phase was acetonitrile/
deionized water, 70 : 30 (v/v), at a flow rate of 1 mL min−1.
Sugar identification was performed by comparing the relative
retention times of sample peaks with standards. Data were
analyzed using Clarity 2.4 Software (DataApex, Podohradska,
Czech Republic). Quantification was based on the RI signal
response of each standard, using the IS (melezitose) method
and by using the calibration curves obtained for the commer-
cial standards of each compound. The results were expressed
in g per 100 g of dry weight.
Organic acids. Organic acids were determined following
a procedure previously optimized and described by the
authors.16 The analysis was performed using a Shimadzu 20A
series ultra-fast liquid chromatograph (UFLC) (Shimadzu
Corporation, Kyoto, Japan). Separation was achieved on a
SphereClone (Phenomenex, Torrance, CA, USA) reverse phase
C18 column (5 μm, 4.6 × 250 mm) thermostatted at 35 °C. The
elution was performed with 3.6 mM sulphuric acid using a
flow rate of 0.8 mL min−1. Detection was carried out with a
diode array detector (DAD), using 215 nm and 245 nm (for
ascorbic acid) as the preferred wavelengths. The organic acids
found were quantified by comparison of the area of their
peaks, recorded at 215 or 245 nm, with the calibration curves
obtained for commercial standards of each compound. The
results were expressed in g per 100 g of dry weight.
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2.3.3. Lipophilic compounds
Fatty acids. Fatty acids were determined after transesterifica-
tion according to the procedure previously described by the
authors.15 The fatty acid profile was analyzed with a DANI
1000 gas chromatograph (GC) equipped with a split/splitless
injector, a flame ionization detector (FID) and a Macherey-
Nagel (Düren, Germany) column (50% cyanopropyl-methyl–
50% phenylmethylpolysiloxane, 30 m × 0.32 mm i.d. × 0.25 µm
df). The oven temperature program was as follows: the initial
temperature of the column was 50 °C, held for 2 min, then a
30 °C per min ramp to 125 °C, 5 °C per min ramp to 160 °C,
20 °C per min ramp to 180 °C, 3 °C per min ramp to 200 °C,
20 °C per min ramp to 220 °C and held for 15 min. The carrier
gas (hydrogen) flow-rate was 4.0 mL min−1 (0.61 bar),
measured at 50 °C. Split injection (1 : 40) was carried out at
250 °C. Fatty acid identification was performed by comparing
the relative retention times of the sample’s FAME peaks with
standards. The results were recorded and processed using
Clarity 4.0.1.7 Software (DataApex, Podohradska, Czech
Republic) and expressed as a relative percentage of each fatty
acid.
Tocopherols. Tocopherols were determined following a pro-
cedure previously described by the authors.15 The analysis was
performed by HPLC (equipment described in Section 2.3.2,
sub section Free sugars), using a fluorescence detector
(FP-2020; Jasco, Easton, MD, USA) programmed for excitation
at 290 nm and emission at 330 nm. The chromatographic
separation was achieved with a Polyamide II (YMC Waters,
Milford, MA, USA) normal-phase column (5 μm, 4.6 mm ×
250 mm), operating at 35 °C. The mobile phase used was a
mixture of n-hexane and ethyl acetate (70 : 30, v/v) at a flow rate
of 1 mL min−1. The compounds were identified by chromato-
graphic comparison with authentic standards. Quantification
was based on the fluorescence signal response of each stan-
dard, using the IS (tocol) method, and the calibration curves
obtained for commercial standards of each compound. The
results were expressed in mg per 100 g of dry weight.
2.4. Preparation of organic and aqueous extracts
The organic (hexane, dichloromethane, ethyl acetate, acetone
and methanol) and aqueous (obtained by infusion and decoc-
tion) extracts were prepared from the lyophilized plant.
For the preparation of the organic extracts a sample (100 g)
was extracted with 500 mL of n-hexane and the mixture was
stirred vigorously at room temperature, 150 rpm, for 48 h, and
then filtered under reduced pressure successively through a
Whatman No. 541 paper and a sintered glass funnel. The solid
residue was extracted with an additional 500 mL of n-hexane
under the same conditions. The combined extracts were
evaporated to dryness at 40 °C under reduced pressure. The
resulting residue was further extracted sequentially with
dichloromethane, ethyl acetate, acetone and finally methanol,
according to the procedure described above.
The infusions were prepared by adding the sample (1 g) to
100 mL of boiling distilled water, left to stand at room temp-
erature for 5 min, and then filtered under reduced pressure
successively through a Whatman No. 541 paper and a sintered
glass funnel. The obtained infusions were frozen and
lyophilized.
The decoctions were also prepared by adding the sample
(1 g) to 100 mL of distilled water and boiled for 5 min. The
mixture was left to stand for 5 min at room temperature and
then filtered under reduced pressure successively through a
Whatman No. 541 paper and a sintered glass funnel. The
obtained decoctions were frozen and lyophilized.
2.5. Bioactive compounds in the extracts
For total phenolics determination, an aliquot of the diﬀerent
extracts (1 mL, 78–625 μg mL−1) were mixed separately, with
Folin–Ciocalteu reagent (5 mL, previously diluted with water
1 : 10 v/v) and sodium carbonate (75 g L−1, 4 mL). The tubes
were vortexed for 15 s and allowed to stand for 30 min at 40 °C
for color development. Absorbance was then measured at
765 nm.17 Gallic acid was used to calculate the standard curve
(0.1–1 mM) and the results were expressed as mg of gallic acid
equivalents (GAE) per g of extract.
For total flavonoids determination, an aliquot of the
diﬀerent extracts (0.5 mL, 313–625 μg mL−1) were mixed separ-
ately, with distilled water (2 mL) and subsequently with NaNO2
solution (5%, 0.15 mL). After 6 min, AlCl3 solution (10%,
0.15 mL) was added and allowed to stand further 6 min, there-
after, NaOH solution (4%, 2 mL) was added to the mixture.
Immediately, distilled water was added to bring the final
volume to 5 mL. Then the mixture was mixed properly and
allowed to stand for 15 min. The intensity of the pink color
was measured at 510 nm.18 Catechin was used to calculate the
standard curve (0.3–1 mM) and the results were expressed as
mg of catechin equivalents (CE) per g of extract.
2.6. Evaluation of bioactive properties of the extracts
2.6.1. Antioxidant activity assays. The organic extracts were
redissolved in methanol (final concentration 10 mg mL−1).
The aqueous extracts were redissolved in water (final concen-
tration 10 mg mL−1). The final solutions obtained were further
diluted to diﬀerent concentrations to be subjected to distinct
evaluation assays of the antioxidant activity.
DPPH radical-scavenging activity was evaluated by using an
ELX800 microplate reader (Bio-Tek Instruments, Inc.;
Winooski, VT, USA), and calculated as a percentage of DPPH
discoloration using the formula: [(ADPPH − AS)/ADPPH] × 100,
where AS and ADPPH are, respectively, the absorbance of the
sample solution and that of the DPPH solution at 515 nm.
Reducing power was evaluated by the capacity to convert Fe3+
into Fe2+, measuring the absorbance at 690 nm in the micro-
plate reader mentioned above. Inhibition of β-carotene bleach-
ing was evaluated through the β-carotene/linoleate assay; the
neutralization of linoleate free radicals avoids β-carotene
bleaching, which is measured by the formula: (β-carotene
absorbance after 2 h of assay/initial absorbance) × 100. Lipid
peroxidation inhibition in porcine (Sus scrofa) brain homo-
genates was evaluated by the decrease in thiobarbituric acid
reactive substances (TBARS); the color intensity of the
Paper Food & Function
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malondialdehyde–thiobarbituric acid (MDA–TBA) was
measured by its absorbance at 532 nm; the inhibition ratio
(%) was calculated using the following formula: [(A − B)/A] ×
100%, where A and B are the absorbance of the control and
the sample solution, respectively.16,19
The results were expressed in EC50 values (sample con-
centration providing 50% of antioxidant activity or 0.5 of
absorbance in the reducing power assay). Trolox was used as
positive control.
2.6.2. Cytotoxicity in human tumor cell lines. The aqueous
and organic extracts were redissolved in water and ethanol
20%, respectively, in order to obtain a final concentration of
8 mg mL−1. The final solution was further diluted to diﬀerent
concentrations (400 to 1.5 µg mL−1) to be subjected to in vitro
cytotoxicity evaluation. Four human tumor cell lines were
used: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small
cell lung cancer), HeLa (cervical carcinoma) and HepG2 (hepato-
cellular carcinoma). The cells were routinely maintained as
adherent cell cultures in RPMI-1640 medium containing 10%
heat-inactivated FBS (MCF-7 and NCI-H460) and 2 mM glut-
amine or in DMEM supplemented with 10% FBS, 2 mM glut-
amine, 100 U per mL penicillin and 100 mg per mL
streptomycin (HeLa and HepG2 cells), at 37 °C, in a humidi-
fied air incubator containing 5% CO2. Each cell line was plated
at an appropriate density (7.5 × 103 cells per well for MCF-7
and NCI-H460 or 1.0 × 104 cells per well for HeLa and HepG2)
in 96-well plates and allowed to attach for 24 h. The cells were
then treated for 48 h with the diﬀerent diluted sample solu-
tions. Following this incubation period, the adherent cells
were fixed by adding cold 10% TCA (100 μL) and incubated for
60 min at 4 °C. Plates were then washed with deionized water
and dried; SRB solution (0.1% in 1% acetic acid, 100 μL) was
then added to each plate-well and incubated for 30 min at
room temperature. Unbound SRB was removed by washing
with 1% acetic acid. Plates were air-dried, the bound SRB was
solubilised with 10 mM Tris (200 μL, pH 7.4) and the absor-
bance was measured at 540 nm in the microplate reader men-
tioned above.16 The results were expressed in GI50 values
(sample concentration that inhibited 50% of the net cell
growth). Ellipticine was used as positive control.
2.6.3. Hepatotoxicity in non-tumor cells. A cell culture was
prepared from a freshly harvested porcine liver obtained from
a local slaughter house, and it was designed as PLP2. Briefly,
the liver tissues were rinsed in Hank’s balanced salt solution
containing 100 U per mL penicillin, 100 µg per mL strepto-
mycin and divided into 1 × 1 mm3 explants. Some of these
explants were placed in 25 cm2 tissue flasks in DMEM
medium supplemented with 10% fetal bovine serum, 2 mM
nonessential amino acids and 100 U per mL penicillin, 100 mg
per mL streptomycin and incubated at 37 °C under a humidi-
fied atmosphere containing 5% CO2. The medium was
changed every two days. Cultivation of the cells was continued
with direct monitoring every two to three days using a phase
contrast microscope. Before confluence was reached, cells were
subcultured and plated in 96-well plates at a density of 1.0 ×
104 cells per well, and cultivated in DMEM medium with 10%
FBS, 100 U per mL penicillin and 100 µg per mL strepto-
mycin.15,16 Cells were treated for 48 h with the diﬀerent
diluted sample solutions and the same procedure described in
the previous section for the SRB assay was followed. The
results were expressed in GI50 values (sample concentration
that inhibited 50% of the net cell growth). Ellipticine was used
as positive control.
2.7. Phenolic composition of the acetone extract
The acetone extract was redissolved in water/methanol 80 : 20
(v/v) (final concentration 5 mg mL−1). Phenolic compounds
were determined by HPLC (Hewlett-Packard 1100 chromato-
grapher, Agilent Technologies, Santa Clara, CA, USA) as previously
described by the authors.16,19 Double online detection was
carried out with a DAD using 280 nm and 370 nm as preferred
wavelengths and with a mass spectrometer (MS) connected to
the HPLC system via the DAD cell outlet. The phenolic com-
pounds were identified by comparing their retention time, UV-
vis and mass spectra with those obtained from standard com-
pounds, when available. Otherwise, peaks were tentatively
identified comparing the obtained information with the avail-
able data reported in the literature. For quantitative analysis, a
calibration curve for each available phenolic standard was con-
structed based on the UV signal. For the identified phenolic
compounds for which a commercial standard was not avail-
able, the quantification was performed through the calibration
curve of other compound from the same phenolic group. The
results were expressed in mg per g of extract.
2.8. Statistical analysis
For all the experiments, three samples were analyzed and all
the assays were carried out in triplicate. The results are
expressed as mean values ± standard deviation (SD). The diﬀer-
ences between the diﬀerent samples were analyzed using one-
way analysis of variance (ANOVA) followed by Tukey’s honestly
significant diﬀerence post hoc test with α = 0.05, coupled with
Welch’s statistic. This treatment was carried out using the
SPSS v. 22.0 program.
3. Results and discussion
3.1. Chemical characterization of Geranium molle L.
The results of the nutritional characterization of G. molle,
namely, macronutrients, sugars, organic acids and fatty acids,
are presented in Table 1. Carbohydrates were the most abun-
dant macronutrients found in the studied sample, followed by
proteins, fat and ash. This plant showed 72.2% of moisture
and the energetic contribution was ∼436 kcal per 100 g dw.
Fructose, glucose and sucrose were the free sugars detected
in this sample. The total sugar content was ∼9 g per 100 g dw,
glucose being present in a much larger amount (∼6 g per
100 g dw) than the two other sugars.
A total of six diﬀerent organic acids were detected in the
plant, namely, oxalic, quinic, malic, ascorbic, citric and
fumaric acids (Table 1). Malic acid was the most abundant
Food & Function Paper
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(∼2.8 g per 100 g dw), followed by quinic acid (∼2.6 g per
100 g dw).
Twenty-eight fatty acids (FA) were determined in G. molle
(Table 1). Highest percentages were found for oleic (C18:1n9),
palmitic (C16:0) and stearic acids (C18:0). Saturated fatty acids
(SFA) predominated over monounsaturated fatty acids (MUFA)
and polyunsaturated fatty acids (PUFA).
Regarding tocopherols, α-tocopherol (18.9 mg per 100 g dw)
was the most abundant isoform present in G. molle.
β-Tocopherol and γ-tocopherol were present but in very small
amounts. δ-Tocopherol was not detected in this plant.
3.2. Bioactive compounds in diﬀerent Geranium molle
L. extracts
Concentrations of total polyphenols and total flavonoids, as
determined by photometrical methods in diﬀerent G. molle
extracts are presented in Table 2. The acetone extract displayed
the highest content of both total polyphenols (497 mg GAE per
g extract) and total flavonoids (112 mg CE per g extract).
Acetone has been reported as a good solvent for the extraction
of phenolic compounds and flavonoids.20,21 The infusion and
the decoction presented similar concentrations of total flavo-
noids but somewhat diﬀerent content of total polyphenols, the
extract resulting from the infusion being richer in this group
of compounds. The dichloromethane and the n-hexane
extracts showed very low concentrations of both total poly-
phenols and total flavonoids.
3.3. Bioactive properties of diﬀerent Geranium molle
L. extracts
The in vitro antioxidant and cytotoxic properties of diﬀerent
extracts of G. molle were evaluated, and the results are pre-
sented in Table 3. The antioxidant activity was determined by
free radical (DPPH) scavenging activity, reducing power, inhi-
bition of lipid peroxidation in brain cell homogenates, and
TBARS assays. The cytotoxicity was tested against human
tumor cell lines (breast, lung, cervical and hepatocellular carci-
nomas) and the hepatotoxicity was evaluated using a porcine
liver primary cell culture.
In general, all the extracts revealed antioxidant potential.
The acetone extract displayed the highest antioxidant activity
in all the assays. This was probably related to the higher
content of total phenols and total flavonoids found in this
extract, compared to the other prepared extracts (Table 2). The
Table 1 Chemical characterization of Geranium molle L. in terms of macronutrients, and hydrophilic and lipophilic compounds
Quantity Quantity
Macronutrients C14:1 0.14 ± 0.01
Moisture (g per 100 g fw) 72.2 ± 0.3 C15:0 0.95 ± 0.01
Fat (g per 100 g dw) 15.5 ± 0.5 C16:0 24.43 ± 0.01
Proteins (g per 100 g dw) 20.9 ± 0.4 C16:1 0.69 ± 0.01
Ash (g per 100 g dw) 10.5 ± 0.1 C17:0 1.21 ± 0.01
Carbohydrates (g per 100 g dw) 53.1 ± 0.2 C18:0 17.2 ± 0.2
Energy (kcal per 100 g dw) 436 ± 2 C18:1n9 26.1 ± 0.1
C18:2n6 4.58 ± 0.07
Hydrophilic compounds C18:3n3 5.56 ± 0.01
Fructose 1.62 ± 0.01 C20:0 0.72 ± 0.02
Glucose 6.32 ± 0.01 C20:1 0.08 ± 0.01
Sucrose 0.99 ± 0.01 C20:2 0.034 ± 0.002
Sum of sugars (g per 100 g dw) 8.93 ± 0.02 C20:3n6 0.08 ± 0.01
Oxalic acid 0.71 ± 0.01 C20:4n6 0.39 ± 0.01
Quinic acid 2.6 ± 0.3 C20:3n3 + C21:0 0.18 ± 0.01
Malic acid 2.821 ± 0.002 C20:5n3 0.20 ± 0.01
Ascorbic acid 0.362 ± 0.001 C22:0 0.47 ± 0.01
Citric acid 1.09 ± 0.05 C22:1n9 0.038 ± 0.001
Fumaric acid 0.0063 ± 0.0001 C22:6n3 0.22 ± 0.01
Sum of organic acids (g per 100 g dw) 7.6 ± 0.3 C24:0 0.30 ± 0.01
C24:1 0.043 ± 0.001
Lipophilic compounds SFA (%) 61.64 ± 0.18
C6:0 2.11 ± 0.01 MUFA (%) 27.12 ± 0.09
C8:0 1.39 ± 0.01 PUFA (%) 11.24 ± 0.08
C10:0 3.35 ± 0.01 α-Tocopherol 18.9 ± 0.6
C11:0 0.022 ± 0.001 β-Tocopherol 0.33 ± 0.01
C12:0 1.98 ± 0.01 γ-Tocopherol 0.76 ± 0.01
C13:0 0.063 ± 0.004 Sum of tocopherols (mg per 100 g dw) 19.99 ± 0.55
C14:0 7.39 ± 0.01
(C6:0), caproic acid; (C8:0), caprylic acid; (C10:0), capric acid; (C11:0), undecylic acid; (C12:0), lauric acid; (C13:0), tridecanoic acid; (C14:0),
myristic acid; (C14:1), myristoleic acid; (C15:0), pentadecanoic acid; (C16:0), palmitic acid; (C16:1), palmitoleic acid; (C17:0), heptadecanoic acid;
(C18:0), stearic acid; (C18:1n9c+t), oleic acid; (C18:2n6c), linoleic acid; (C18:3n3), α-linolenic acid; (C20:0), arachidic acid; (C20:1), cis-11-
eicosenoic acid; (C20:2), cis-11,14-Eicosadienoic acid; (C20:3n6), eicosatrienoic acid; (C20:4n6), arachidonic acid; (C20:3n3 + C21:0), cis-11,14,17-
eicosatrienoic acid and heneicosanoic acid; (C20:5n3), eicosapentaenoic acid; (C22:0), behenic acid; (C22:1n9), Erucic acid; (C22:6n3),
docosahexaenoic acid; (C24:0), lignoceric acid; (C24:1), nervonic acid; SFA – saturated fatty acids; MUFA – monounsaturated fatty acids; PUFA –
polyunsaturated fatty acids; fw – fresh weight; dw – dry weight.
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antioxidant properties of many plants are closely related to the
presence of phenolic compounds, which constitute the most
abundant secondary metabolites of plants.22
Regarding the cytotoxic properties, almost all of the extracts
showed activity. The aqueous extract obtained by infusion, and
methanol and ethyl acetate extracts showed similar cytotoxic
eﬀects against MCF-7, NCI-H460 and HeLa cells. The dichloro-
methane extract was ineﬀective against the HepG2 cell line
even at the maximum concentration assayed (400 µg mL−1).
The n-hexane extract showed activity only against HeLa cells.
The acetone extract displayed the highest cytotoxic eﬀect,
being significantly more potent than the remaining extracts
(GI50 values approximately four times lower) against all cell
lines. Unfortunately, this extract also presented the highest
toxicity against normal primary cells from the porcine liver
(PLP2) (GI50 ∼ 190 μg mL−1). However, the concentration
required to reach 50% of growth inhibition of PLP2 is about
3–4 times higher than the concentration required to achieve
50% of growth inhibition of the human tumor cell lines tested.
Therefore, a dosage of 85 µg mL−1 of the G. molle acetone
extract would be recommended to guarantee 50% of growth
inhibition of the human tumor cell lines tested, without
presenting toxicity eﬀects for non-tumor cells.
The aqueous, dichloromethane and n-hexane extracts did
not show hepatotoxicity against PLP2 cells up to the maximal
tested concentration (GI50 > 400 μg mL−1). The methanol and
ethyl acetate extracts presented similar hepatotoxicity against
this cell line (GI50 ∼ 330 μg mL−1).
Trolox and ellipticine were used as positive controls in the
antioxidant and cytotoxic activity assays, respectively. However,
as these are individual compounds, they should not be con-
sidered as standards and comparison with the results obtained
for the extracts/oral preparations should be avoided since
an eventual synergistic eﬀect of the mixtures cannot be
precluded.
3.4. Analysis of phenolic compounds in the acetone extract
Amongst the several G. molle extracts prepared, the acetone
extract was found to exhibit the highest amount of total pheno-
lic compounds, as well as the highest antioxidant and cytotoxic
activity, so that its detailed phenolic composition was also
analysed. The HPLC phenolic profile of that extract recorded at
280 and 370 nm is shown in Fig. 1. The peak characteristics
and tentative identities are presented in Table 4. Sixteen
phenolic compounds were detected, five of which were
ellagitannins, one phenolic acid and ten flavonoids.
Table 2 Bioactive compounds in diﬀerent Geranium molle L. extracts
Extracts
Aqueous extracts Organic extracts
Infusion Decoction n-Hexane Dichloromethane Ethyl acetate Acetone Methanol
Total Polyphenols (mg GAE per g extract) 79 ± 1c 63 ± 1d 13 ± 1e 6.15 ± 0.03f 216 ± 2b 497 ± 8a 76 ± 5c
Total Flavonoids (mg CE per g extract) 27 ± 1d 25.1 ± 0.2d 4.5 ± 0.4e 2.1 ± 0.02e 74 ± 6b 112 ± 1a 53 ± 3c
GAE – gallic acid equivalents; CE – catechin equivalents. In each row diﬀerent letters mean significant diﬀerences (p < 0.05).
Table 3 Bioactive properties of diﬀerent Geranium molle L. extracts
Aqueous extracts Organic extracts
Infusion Decoction n-Hexane Dichloromethane Ethyl acetate Acetone Methanol
Antioxidant activity (EC50, µg mL
−1)
DPPH scavenging activity 324 ± 9b 248 ± 4c 1816 ± 126a >10 000 128 ± 5d 18.9 ± 0.5e 135 ± 3d
Reducing power 141 ± 1c 170 ± 6b 266 ± 5a 265 ± 1a 51 ± 1e 20.3 ± 0.2f 105 ± 4d
β-Carotene bleaching inhibition 197 ± 8e 249 ± 9b 226 ± 4c 253 ± 11b 212 ± 5d 61 ± 3f 274 ± 6a
TBARS inhibition 54 ± 3d 144 ± 7a 98 ± 4c 130 ± 6b 34 ± 2e 6.5 ± 0.2f 38 ± 2e
Antitumor activity (GI50 values, µg mL
−1)
MCF-7 (breast carcinoma) 225 ± 15b 187 ± 9c >400 370 ± 20a 215 ± 14b 85 ± 13d 229 ± 17b
NCI-H460 (non-small lung cancer) 190 ± 16bc 172 ± 3c >400 256 ± 17a 200 ± 14b 63 ± 4d 206 ± 8b
HeLa (cervical carcinoma) 226 ± 19b 267 ± 18a 211 ± 18b 234 ± 21b 232 ± 15b 56 ± 5c 204 ± 15b
HepG2 (hepatocellular carcinoma) 241 ± 14a 170 ± 13c >400 >400 204 ± 16b 50 ± 4d 260 ± 13a
Hepatotoxicity (GI50 value, µg mL
−1)
PLP2 >400 >400 >400 >400 338 ± 12a 191 ± 15b 332 ± 32a
The antioxidant activity was expressed as EC50 values, which means that higher values correspond to lower reducing power or antioxidant poten-
tial. EC50: extract concentration corresponding to 50% of antioxidant activity or 0.5 of absorbance in reducing power assay. Trolox EC50 values:
41 µg mL−1 (reducing power), 42 µg mL−1 (DPPH scavenging activity), 18 µg mL−1 (β-carotene bleaching inhibition) and 23 µg mL−1 (TBARS inhi-
bition). GI50 values correspond to the sample concentration achieving 50% of growth inhibition in human tumour cell lines or in liver primary
culture PLP2. Ellipticine GI50 values: 1.21 µg mL
−1 (MCF-7), 1.03 µg mL−1 (NCI-H460), 0.91 µg mL−1 (HeLa), 1.10 µg mL−1 (HepG2) and
2.29 µg mL−1 (PLP2). In each row diﬀerent letters mean significant diﬀerences (p < 0.05).
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(+)-Catechin (compound 3), 5-O-caﬀeoylquinic acid (com-
pound 4), luteolin-6-C-glucoside (compound 9), quercetin-3-O-
rutinoside (compound 10), apigenin-6-C-glucoside (compound
12), quercetin-3-O-glucoside (compound 13), kaempferol-3-O-
rutinoside (compound 14) and kaempferol-3-O-glucoside (com-
pound 16) were positively identified according to their reten-
tion, mass and UV-vis characteristics by comparison with
commercial standards.
Compounds 1, 2 and 5–7 were identified as hydrolysable
tannins (ellagitannin derivatives) and assigned as diﬀerent
hexahydroxydiphenoyl (HHDP)-glucose esters based on their
pseudomolecular ions and fragmentation patterns. Thus, the
mass characteristics of compound 1 ([M − H]− at m/z 633)
pointed to a galloyl-HHDP-glucose isomer, whereas those of
compounds 2 and 5 ([M − H]− at m/z 785) were consistent with
digalloyl-HHDP-glucose isomers, and compounds 6 and 7 with
bis-HHDP-glucose isomers.23,24 Similar compounds have been
described in other Geranium species;10,25–31 actually HHDP
esters are considered as the main hydrolysable tannins
and majority phenolic compounds in most species of
Geranium.10,25,27,32,33 However, to the best of our knowledge,
they have never been reported in G. molle.
The remaining compounds would correspond to flavonoids.
Compounds 8 ([M − H]− at m/z 755) and 15 ([M − H]− at m/z
Fig. 1 Phenolic proﬁle of Geranium molle L. acetone extract recorded at 370 nm (A) and 280 nm (B).
Table 4 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, identiﬁcation and quantiﬁcation of
phenolic compounds of the acetone extract of Geranium molle L.
Peak
Rt
(min)
λmax
(nm)
Molecular ion
[M − H]− (m/z) MS2 (m/z) Tentative identification
Quantification
(mg g−1)
1 4.7 278 633 463(5), 421(3), 301(82), 275(49), 169(8) Galloyl-HHDP-glucose 4.8 ± 0.1
2 6.1 276 785 633(9), 615(10), 483(15), 301(64), 275(30), 169(7) Digalloyl-HHDP-glucose 61 ± 4
3 7.7 278 289 245(40), 203(30), 187(40), 161(30), 137(20) (+)-Catechin 16 ± 1
4 7.9 328 353 191(100), 179(47), 173(39), 161(20), 135(25) 5-O-Caﬀeoylquinic acid 7 ± 1
5 8.4 276 785 633(6), 615(8), 483(20), 301(77), 275(28), 169(8) Digalloyl-HHDP-glucose 66 ± 5
6 12.5 276 783 765(77), 721(5), 481(5), 301(13), 275(17) Bis-HHDP-glucose 43 ± 3
7 14.1 278 783 765(89), 721(3), 481(3), 301(17), 275(15) Bis-HHDP-glucose 58 ± 4
8 15.5 358 755 301(100) Quercetin-O-dideoxyhexosyl-hexoside 0.18 ± 0.01
9 16.0 350 447 429(15), 357(90), 327(80), 297(50), 285(21) Luteolin-6-C-glucoside 4.7 ± 0.3
10 17.0 358 609 301(100) Quercetin-3-O-rutinoside 0.37 ± 0.03
11 18.9 340 563 443(17), 413(33), 311(67), 293(33) Apigenin 2″-O-pentosyl-6-C-hexoside 0.69 ± 0.04
12 19.7 336 431 413(5), 341(40), 311(100), 283(53) Apigenin-6-C-glucoside 1.53 ± 0.10
13 20.1 358 463 301(100) Quercetin-3-O-glucoside 0.60 ± 0.02
14 21.1 354 593 285(100) Kaempferol-3-O-rutinoside 0.89 ± 0.01
15 23.1 356 433 301(100) Quercetin-O-pentoside 0.20 ± 0.02
16 24.1 348 447 285(100) Kaempferol-3-O-glucoside 0.36 ± 0.02
Total ellagitannins 234 ± 16
Total hydroxycinnamoyl esters 7 ± 1
Total flavonoids 25 ± 2
Total phenolic compounds 265 ± 19
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447) were associated to quercetin glycosides based on their
absorption spectra and the production of an ion fragment at
m/z 301. Their molecular weights pointed to a quercetin-O-
pentoside (peak 15) and a quercetin derivative bearing two
deoxyhexosyl and one hexosyl residues (peak 8). In the latter
derivative, the fact that only one MS2 fragment was released
corresponding to the aglycone suggests that the three sugars
constituted a trisaccharide. Flavonol derivatives have been pre-
viously described in other Geranium sp. pl., namely diﬀerent
quercetin and kaempferol aglycones and glycoside
derivatives.34–40
Finally compound 11 ([M − H]− at m/z 563) was tentatively
assigned as apigenin 2″-O-pentosyl-6-C-hexoside according to
its pseudomolecular ion and fragmentation pattern. A com-
pound with the same characteristics had been previously
found by our group in Arenaria montana41 and identified based
on the fragmentation patterns described by Ferreres et al.42
and Ferreres et al.43 for O,C-glycosyl flavones. As far as we
know this type of compound is reported herein for the first
time in Geranium species, although some flavone O-glycosides
and aglycones, i.e., luteolin and apigenin, have been reported
in Geranium sp. pl.35,38–40
Digalloyl-HHDP-glucoside (compound 5) was the most
abundant ellagitannin present, while luteolin-6-C-glucoside
(compound 9) was the best represented flavonoid. Chlorogenic
acid (i.e., 5-O-caﬀeoylquinic acid) was the only hydroxy-
cinnamoyl derivative found in the analysed sample.
4. Conclusions
Geranium molle L. is rich in carbohydrates and proteins, pro-
viding tocopherols and essential fatty acids. In general, the
various aqueous and organic extracts showed antioxidant
activity and cytotoxicity against the diﬀerent human tumour
cell lines tested. The acetone extract presented the highest
antioxidant potential in the diﬀerent assays, which is most
probably related to its higher content of polyphenols and flavo-
noids compared with the other prepared extracts. The acetone
extract also displayed the highest cytotoxic eﬀect, being signifi-
cantly more potent than the remaining extracts against all cell
lines (GI50 values approximately four times lower). Although
this extract also presented the highest toxicity against porcine
liver primary cells (PLP2), the GI50 value for PLP2 was about
3–4 times higher than those for the tumor cell lines tested.
The decoction and the infusion of the plant, which are the
common forms of folk consumption, did not show hepato-
toxicity against PLP2 cells up to the maximal tested concen-
tration (400 µg mL−1), but presented GI50 for the tumor cells
3–4 times higher than the acetone extract. The phenolic profile
of the acetone extract was determined by HPLC-MS and shown
to be constituted mainly by ellagitannins, as well as some
flavone and flavonol glycosides. All in all, the obtained results
support the folk medicinal use of G. molle, and its interest as a
source of phytochemicals with bioactive properties to be
explored in the medicine and food industries.
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